Prevalence of Post-Coronavirus Disease Condition 12 Weeks After Omicron Infection Compared With Negative Controls and Association With Vaccination Status.

Nehme, Mayssam; Vetter, Pauline; Chappuis, François; Kaiser, Laurent; Guessous, Idris

Nehme, Mayssam; Vetter, Pauline; Chappuis, François; Kaiser, Laurent; Guessous, Idris.

Afiliação

Nehme M; Division of Primary Care Medicine of the Geneva University Hospitals, Geneva, Switzerland.
Vetter P; Division of Infectious Diseases, Geneva University Hospitals, Geneva, Switzerland.
Chappuis F; Geneva Center for Emerging Viral Diseases, Geneva University Hospitals, Geneva, Switzerland.
Kaiser L; Division of Laboratory Medicine, Laboratory of Virology, Geneva University Hospitals, Geneva, Switzerland.
Guessous I; Division of Tropical and Humanitarian Medicine, Geneva University Hospitals, Geneva, Switzerland.

Clin Infect Dis ; 76(9): 1567-1575, 2023 05 03.

Article em En | MEDLINE | ID: mdl-36519381

Assuntos

COVID-19; Humanos; Prevalência; COVID-19/epidemiologia; SARS-CoV-2; Vacinação

Palavras-chave

Omicron; SARS-CoV-2; persistent symptoms; post-COVID; vaccination

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: COVID-19 Idioma: En Ano de publicação: 2023 Tipo de documento: Article